- All Devices
- Radiology
- OsteoSight Hip (v1)
Radiology
OsteoSight Hip (v1)
Naitive Technologies Ltd
This device is software which opportunistically assesses radiological images to estimate bone mineral density (BMD) intended to assist in a healthcare professional's decision to evaluate patients for possible low BMD within a bone health screening program. The software employs an algorithm that estimates BMD using eligible radiological image data obtained for other clinical purposes.
FDA Submission Metadata
- Submission number
- K251408
- Decision date
- September 2025
- FDA panel
- Radiology
- Product code
- SAO
This entry is sourced from the FDA AI/ML-Enabled Medical Devices list. No editorial review yet — the catalogue may add a deeper review of this device in future.
This entry is on our editorial review queue. Full evaluation — performance metrics, clinical evidence, safety record — lands as our review pipeline graduates each device. The information above is what's been verified to date.